Ribo-21: rna-based broad-spectrum plant disease resistance agent

Overview

Ribo-21 is a naturally occurring RNA molecule conserved across all plants that triggers systemic acquired resistance (SAR), a whole-plant immune response providing broad-spectrum protection against major foliar and soil-borne pathogens. When applied to leaves, Ribo-21 is rapidly transported throughout the plant, conferring robust resistance in both treated and systemic tissues without causing energy-intensive, non-specific defense activation that can reduce yields. This makes Ribo-21 an attractive, cost-effective disease protection agent for commercial crop production in field conditions.

Validated efficacy spans fungal, oomycete, bacterial, and viral pathogens across multiple crops including Arabidopsis thaliana, soybean, and tobacco. The technology is backed by a patent application currently under review and originates from the University of Kentucky's plant pathology research program.

Technical specifications

Key features and mechanism:

• Ribo-21 is highly conserved across plant species and functions as a strong inducer of SAR
• Exogenous leaf application triggers systemic disease resistance throughout the plant
• Both nascent pre- and processed RNA species show comparable resistance-inducing efficacy
• Molecular data indicates Ribo-21 works by inhibiting negative regulators of SAR
• The molecule can be synthesized in the laboratory, enabling scalable production

Current and planned optimizations:

• Ribose modifications and phosphate replacement with phosphothioate or boranophosphate to improve half-life and stability
• Nucleotide modifications and methyl linkage-derived ribose residue locking to enhance nuclease resistance
• Nanoparticle-based delivery systems for improved field applicability
• Conjugate formulations assessed for delivery efficiency, in-planta molecular effects, and field-level disease resistance

Technology readiness level

Ribo-21 has completed initial laboratory validation demonstrating SAR activation and broad-spectrum pathogen resistance in multiple plant species. Proof-of-concept studies confirmed that mutant plants unable to synthesize endogenous Ribo-21 show compromised SAR, which is rescued by exogenous application, establishing the molecule's mechanistic role. Current efforts are focused on formulation optimization—including chemical modifications for nuclease resistance and nanoparticle delivery systems—to transition from laboratory application methods (leaf spray and infiltration) toward field-ready formulations. The technology is positioned for further development through partnerships focused on agricultural formulation, delivery optimization, and field validation.